Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 2 (2005), Issue 2 (February)

1. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
   Cancer, 103(3): 616-24. [Abstract] [Full-text]
2. Sun exposure and mortality from melanoma.
   J Natl Cancer Inst, 97(3): 195-9. [Abstract] [Full-text]
3. PUMA expression is significantly reduced in human cutaneous melanomas.
   Oncogene, 24(6): 1111-6. [Abstract] [Full-text]
4. Nevus sebaceus of Jadassohn revisited with reconstruction options.
   Int J Dermatol, 44(2): 145-50. [Abstract] [Full-text]
5. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
   Int J Dermatol, 44(2): 116-20. [Abstract] [Full-text]
6. Awareness, knowledge and attitudes to non-melanoma skin cancer and actinic keratosis among the general public.
   Int J Dermatol, 44(2): 107-11. [Abstract] [Full-text]
7. FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma.
   J Pathol, 205(3): 302-10. [Abstract] [Full-text]
8. Merkel cell carcinoma: changing incidence trends.
   J Surg Oncol, 89(1): 1-4. [Abstract] [Full-text]
9. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.
   Blood, 105(4): 1640-7. [Abstract] [Full-text]
10. Heterogeneous antibody response to polyvalent melanoma vaccines in syngeneic mice.
    Cancer Immunol Immunother, 54(4): 345-50. [Abstract] [Full-text]
11. ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patients.
    Hematol J, 5(7): 553-8. [Abstract] [Full-text]
12. Imiquimod in the treatment of extensive recurrent lentigo maligna.
    J Am Acad Dermatol, 52(2): 51-2. [Abstract] [Full-text]
13. A case of Spitz nevus with multiple satellite lesions.
    J Am Acad Dermatol, 52(2): 48-50. [Abstract] [Full-text]
14. Classic Kaposi's sarcoma in the Inuit of northern Quebec.
    J Am Acad Dermatol, 52(2): 31-4. [Abstract] [Full-text]
15. Treatment of scalp angiosarcoma by controlled perfusion of A. carotis externa with pegylated liposomal doxorubicin and intralesional application of pegylated interferon alfa.
    J Am Acad Dermatol, 52(2): 20-3. [Abstract] [Full-text]
16. Basal cell carcinoma and World War II-era cathode ray oscilloscope exposure.
    J Am Acad Dermatol, 52(2): 1-7. [Abstract] [Full-text]
17. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery.
    J Am Acad Dermatol, 52(2): 295-300. [Abstract] [Full-text]
18. Analysis of 197 female scalp tumors treated with Mohs micrographic surgery.
    J Am Acad Dermatol, 52(2): 291-4. [Abstract] [Full-text]
19. Ultrapotent topical corticosteroid treatment of hemangiomas of infancy.
    J Am Acad Dermatol, 52(2): 281-6. [Abstract] [Full-text]
20. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
    J Am Acad Dermatol, 52(2): 275-80. [Abstract] [Full-text]
21. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management.
    J Am Acad Dermatol, 52(2): 197-203. [Abstract] [Full-text]
22. Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.
    Eur J Cancer, 41(3): 386-92. [Abstract] [Full-text]
23. Colors in atypical nevi: a computer description reproducing clinical assessment.
    Skin Res Technol, 11(1): 36-41. [Abstract] [Full-text]
24. Automatic lesion boundary detection in dermoscopy images using gradient vector flow snakes.
    Skin Res Technol, 11(1): 17-26. [Abstract] [Full-text]
25. Predictive power of irregular border shapes for malignant melanomas.
    Skin Res Technol, 11(1): 1-8. [Abstract] [Full-text]
26. Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies.
    Mol Carcinog, 42(2): 65-92. [Abstract] [Full-text]
27. Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members.
    Cancer Immunol Immunother, 54(4): 359-71. [Abstract] [Full-text]
28. Evaluation of tumor-specific promoter activities in melanoma.
    Gene Ther, 12(4): 330-8. [Abstract] [Full-text]
29. Bowen's disease of the nipple-a new method of treatment.
    Breast, 14(1): 65-7. [Abstract] [Full-text]
30. Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.
    Gene Ther, 12(4): 339-46. [Abstract] [Full-text]
31. Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin.
    J Cutan Pathol, 32(3): 245-50. [Abstract] [Full-text]
32. Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.
    J Cutan Pathol, 32(3): 227-34. [Abstract] [Full-text]
33. Bone morphogenetic protein-mediated type II collagen expression in pilomatricoma and cutaneous mixed tumor.
    J Cutan Pathol, 32(3): 206-11. [Abstract] [Full-text]
34. Ultraviolet radiation and skin cancer: molecular mechanisms.
    J Cutan Pathol, 32(3): 191-205. [Abstract] [Full-text]
35. Second primary cancers in patients with squamous cell carcinoma of the skin.
    Br J Cancer, 92(3): 570-1. [Abstract] [Full-text]
36. Imatinib-induced regression of AIDS-related Kaposi's sarcoma.
    J Clin Oncol, 23(5): 982-9. [Abstract] [Full-text]
37. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.
    Mod Pathol, 18(2): 197-204. [Abstract] [Full-text]
38. Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma.
    Hum Gene Ther, 16(1): 91-100. [Abstract] [Full-text]
39. Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy.
    Hum Gene Ther, 16(1): 35-48. [Abstract] [Full-text]
40. An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesis.
    Oncogene, 24(7): 1174-87. [Abstract] [Full-text]
41. Hereditary cancer syndromes of the skin.
    Clin Dermatol, 23(1): 85-106. [Abstract] [Full-text]
42. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications.
    Cancer Treat Rev, 31(1): 18-26. [Abstract] [Full-text]
43. Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain.
    J Biol Chem, 280(7): 5870-4. [Abstract] [Full-text]
44. Views of UK melanoma patients on routine follow-up care.
    Br J Plast Surg, 58(2): 245-50. [Abstract] [Full-text]
45. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma.
    Cancer, 103(4): 780-7. [Abstract] [Full-text]
46. Absence of V599E BRAF mutations in desmoplastic melanomas.
    Cancer, 103(4): 788-92. [Abstract] [Full-text]
47. Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
    Int J Cancer, 114(3): 426-32. [Abstract] [Full-text]
48. Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth.
    Int J Cancer, 114(3): 356-63. [Abstract] [Full-text]
49. Altered expressions of HOX genes in human cutaneous malignant melanoma.
    Int J Cancer, 114(3): 436-41. [Abstract] [Full-text]
50. A peptide derived from melanocytic protein gp100 and presented by HLA-B35 is recognized by autologous cytolytic T lymphocytes on melanoma cells.
    Tissue Antigens, 65(2): 156-62. [Abstract] [Full-text]
51. T-cell prolymphocytic leukemia involving extramedullary sites.
    Am J Clin Pathol, 123(3): 456-64. [Abstract] [Full-text]
52. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1.
    Oncogene, 24(8): 1423-33. [Abstract] [Full-text]
53. Psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study.
    J Clin Oncol, 23(6): 1270-7. [Abstract] [Full-text]
54. Cutaneous melanoma.
    Lancet, 365(9460): 687-701. [Abstract] [Full-text]
55. Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.
    Neoplasia, 7(1): 57-66. [Abstract] [Full-text]
56. Early neoplastic progression is complement independent.
    Neoplasia, 6(6): 768-76. [Abstract] [Full-text]
57. Clinical evaluation of random skin flaps based on the subdermal plexus secured with sutures or sutures and cyanoacrylate adhesive for reconstructive surgery in dogs.
    Vet Surg, 34(1): 59-63. [Abstract] [Full-text]
58. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.
    Ann Oncol, 16(3): 460-5. [Abstract] [Full-text]
59. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck.
    Head Neck, 27(3): 208-16. [Abstract] [Full-text]
60. Protein kinase C epsilon signals ultraviolet light-induced cutaneous damage and development of squamous cell carcinoma possibly through Induction of specific cytokines in a paracrine mechanism.
    Photochem Photobiol, 81(1): 9-18. [Abstract] [Full-text]
61. UV-A fingerprint mutations in human skin cancer.
    Photochem Photobiol, 81(1): 3-8. [Abstract] [Full-text]
62. Protective effect of the isoflavonoid equol against hairless mouse skin carcinogenesis induced by UV radiation alone or with a chemical cocarcinogen.
    Photochem Photobiol, 81(1): 32-7. [Abstract] [Full-text]
63. Ultrasound scanning in dermatology.
    Arch Dermatol, 141(2): 217-24. [Abstract] [Full-text]
64. Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome.
    Arch Dermatol, 141(2): 199-206. [Abstract] [Full-text]
65. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma.
    Arch Dermatol, 141(2): 183-9. [Abstract] [Full-text]
66. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection.
    Arch Dermatol, 141(2): 177-80. [Abstract] [Full-text]
67. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
    Arch Dermatol, 141(2): 165-73. [Abstract] [Full-text]
68. Limitations of dermoscopy in the recognition of melanoma.
    Arch Dermatol, 141(2): 155-60. [Abstract] [Full-text]
69. Microscopic in vivo description of cellular architecture of dermoscopic pigment network in nevi and melanomas.
    Arch Dermatol, 141(2): 147-54. [Abstract] [Full-text]
70. Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer.
    Cancer Lett, 219(2): 197-204. [Abstract] [Full-text]
71. Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study.
    Br J Cancer, 92(4): 673-80. [Abstract] [Full-text]
72. Cutaneous presentation of recurrence of lymphoepithelioid T-cell lymphoma (Lennert's lymphoma).
    Clin Exp Dermatol, 30(2): 155-7. [Abstract] [Full-text]
73. Primary cutaneous ganglioneuroma arising within a seborrheic keratosis: a rare association.
    Clin Exp Dermatol, 30(2): 137-40. [Abstract] [Full-text]
74. Optimizing the cut in Mohs' micrographic surgery in regard to skin sparing and microscopic view: is a round incision cut necessary?
    Clin Exp Dermatol, 30(2): 116-9. [Abstract] [Full-text]
75. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Br J Cancer, 92(4): 662-7. [Abstract] [Full-text]
76. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
    Cancer, 103(5): 1018-25. [Abstract] [Full-text]
77. Kaposi's sarcoma in kidney transplant recipients: a 23-year experience.
    QJM, 98(3): 205-14. [Abstract] [Full-text]
78. Dermoscopy for early detection of facial lentigo maligna.
    Br J Dermatol, 152(2): 361-4. [Abstract] [Full-text]
79. Unusual inflammatory and hyperkeratotic halo naevus in children.
    Br J Dermatol, 152(2): 357-60. [Abstract] [Full-text]
80. Aberrantly differentiated cells in benign pilomatrixoma reflect the normal hair follicle: immunohistochemical analysis of Ca-binding S100A2, S100A3 and S100A6 proteins.
    Br J Dermatol, 152(2): 314-20. [Abstract] [Full-text]
81. Becker's naevus: a comparative study between erbium: YAG and Q-switched neodymium:YAG; clinical and histopathological findings.
    Br J Dermatol, 152(2): 308-13. [Abstract] [Full-text]
82. Dermoscopy of skin lesions in two patients with xeroderma pigmentosum.
    Br J Dermatol, 152(2): 271-8. [Abstract] [Full-text]
83. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
    J Magn Reson Imaging, 21(3): 272-81. [Abstract] [Full-text]
84. Modulation of light-induced skin tumors by N-acetylcysteine and/or ascorbic acid in hairless mice.
    Carcinogenesis, 26(3): 657-64. [Abstract] [Full-text]
85. Tenascin-C in primary Merkel cell carcinoma.
    J Clin Pathol, 58(3): 297-300. [Abstract] [Full-text]
86. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
    J Clin Oncol, 23(7): 1473-82. [Abstract] [Full-text]
87. A mechanism-based antioxidant approach for the reduction of skin carcinogenesis.
    Cancer Res, 65(4): 1401-5. [Abstract] [Full-text]
88. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.
    Cancer Res, 65(4): 1394-400. [Abstract] [Full-text]
89. Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
    Cancer Res, 65(4): 1146-9. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.